AYTU BIOPHARMA, INC Inventory, Finished Goods, Gross
AYTU BIOPHARMA, INC (AYTU) had Inventory, Finished Goods, Gross of $5.98 million as of 2020-12-31, per its 10-Q filed 2021-02-11.
Discontinued › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryFinishedGoods · last filed 2021-02-11
- 2020-12-31: Inventory, Finished Goods, Gross $5.98M.
- 2020-09-30: Inventory, Finished Goods, Gross $1.10M.
- 2020-06-30: Inventory, Finished Goods, Gross $9.60M.
- 2020-03-31: Inventory, Finished Goods, Gross $3.49M.
| Period end | Inventory, Finished Goods, Gross |
|---|---|
| 2020-12-31 | $5.98M 10-Q · filed 2021-02-11 |
| 2020-09-30 | $1.10M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $9.60M 10-Q · filed 2021-02-11 |
| 2020-03-31 | $3.49M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $2.31M 10-Q · filed 2020-02-14 |
| 2019-09-30 | $1.23M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $1.32M 10-K · filed 2020-10-06 |
| 2019-03-31 | $984.00K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $1.16M 10-Q · filed 2019-05-14 |
| 2018-09-30 | $1.03M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $1.10M 10-K · filed 2019-09-26 |
| 2017-06-30 | $738.00K 10-K · filed 2018-09-06 |
| 2016-06-30 | $647.00K 10-K · filed 2017-08-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |